Apple App Store Injunction Largely Upheld as Appeals Court Rules on Epic Games Case 
SK Hynix Considers U.S. ADR Listing to Boost Shareholder Value Amid Rising AI Chip Demand 
Trello Outage Disrupts Users as Access Issues Hit Atlassian’s Work Management Platform 
EU Court Cuts Intel Antitrust Fine to €237 Million Amid Long-Running AMD Dispute 
Adobe Strengthens AI Strategy Ahead of Q4 Earnings, Says Stifel 
SoftBank Shares Slide as Oracle’s AI Spending Plans Fuel Market Jitters 
Moore Threads Stock Slides After Risk Warning Despite 600% Surge Since IPO 
Mizuho Raises Broadcom Price Target to $450 on Surging AI Chip Demand 
Intel’s Testing of China-Linked Chipmaking Tools Raises U.S. National Security Concerns 
U.S. Greenlights Nvidia H200 Chip Exports to China With 25% Fee 
Evercore Reaffirms Alphabet’s Search Dominance as AI Competition Intensifies 
SpaceX Edges Toward Landmark IPO as Elon Musk Confirms Plans 
IBM Nears $11 Billion Deal to Acquire Confluent in Major AI and Data Push 
US Charges Two Men in Alleged Nvidia Chip Smuggling Scheme to China 
Trump Signs Executive Order to Establish National AI Regulation Standard 
U.S.-EU Tensions Rise After $140 Million Fine on Elon Musk’s X Platform 
Taiwan Opposition Criticizes Plan to Block Chinese App Rednote Over Security Concerns 
Today, the United States International Trade Commission (ITC) formally opposed Apple's move to keep the Apple Watch sales restriction in place for the length of its appeal.
ITC Wants Apple Watch Sales Ban Reinstated
In a document filed with the United States in the Court of Appeals for the Federal Circuit, ITC lawyers stated that "Apple presents a weak and unconvincing case to invoke the extraordinary remedy of a stay pending appeal," and that Apple's arguments "amount to little more than an indisputably adjudicated infringer requesting permission to continue infringing the asserted patents."
The court is seeking responses from other parties in support of the ITC's decision until January 15, so the Apple Watch should be available until early next week at the very least, as per MacRumors.
In October, the ITC determined that Apple Watch models with blood oxygen sensing infringed on Masimo's patents, and as a result, the import and sale of these devices in the United States was prohibited. The feature is accessible on Apple Watch Series 6 and later, excluding Apple Watch SE devices.
Masimo has accused Apple of stealing trade secrets and poaching staff to develop blood oxygen-detecting technology. Last month, Masimo stated that it was open to settlement talks, but Apple reportedly showed little interest at the time.
Apple Awaits Customs Ruling on Software Updates
In December, Apple temporarily halted sales of the Apple Watch Series 9 and Apple Watch Ultra 2 in its retail and online locations in the United States. After appealing the ITC's ruling to the U.S. Apple was given a temporary stay by the Court of Appeals for the Federal Circuit, which halted the ban and allowed sales to resume for the time being, according to The Verge.
Apple is purportedly developing software updates to address the alleged patent violation and the U.S. The Customs and Border Protection Agency is anticipated to rule on these adjustments later this week. However, Masimo feels that the Apple Watch's hardware design must change in order to be compatible, and the ITC has also expressed concern.
Photo: Simon Daoudi/Unsplash
